首页> 外国专利> Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

机译:血清抗氧化剂可作为败血症患者成人呼吸窘迫综合征的预测指标

摘要

At the initial diagnosis of sepsis (6-24 h before the development of ARDS), serum manganese superoxide dismutase (MnSOD) levels and catalase activities are increased in septic patients who subsequently developed ARDS compared to septic patients who did not develop ARDS. Increases in MnSOD and catalase may be used to predict the occurrence of ARDS in septic patients with the same sensitivity, specificity and efficiency as parallel assessments of serum lactate dehydrogenase (LDH) and Factor VIII levels. Evaluation of serum MnSOD and catalase as well as these other accessible markers facilitates identification of subsets of patients and allows prospective treatment of septic patients who are destined to develop ARDS.
机译:在脓毒症的初步诊断中(在ARDS发生前6-24小时),与没有发展ARDS的脓毒症患者相比,随后发生ARDS的脓毒症患者血清锰超氧化物歧化酶(MnSOD)水平和过氧化氢酶活性升高。 MnSOD和过氧化氢酶的增加可用于预测败血症患者中ARDS的发生,其敏感性,特异性和效率与血清乳酸脱氢酶(LDH)和VIII因子水平的平行评估相同。血清MnSOD和过氧化氢酶以及这些其他可及的标记物的评估有助于鉴定患者的子集,并允许对注定发展为ARDS的败血症患者进行前瞻性治疗。

著录项

  • 公开/公告号US5389522A

    专利类型

  • 公开/公告日1995-02-14

    原文格式PDF

  • 申请/专利权人 REPINE;JOHN E.;LEFF;JONATHAN A.;

    申请/专利号US19930034935

  • 发明设计人 JONATHAN A. LEFF;JOHN E. REPINE;

    申请日1993-03-19

  • 分类号C12Q1/26;C12Q1/30;G01N33/53;

  • 国家 US

  • 入库时间 2022-08-22 04:05:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号